tradingkey.logo

Eli Lilly FDA Approves Updated Label For Kisunla

ReutersJul 9, 2025 10:50 AM

- Eli Lilly and Co LLY.N:

  • ELI LILLY: FDA APPROVES UPDATED LABEL FOR KISUNLA WITH NEW DOSING IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE

  • ELI LILLY: NEWLY RECOMMENDED DOSING SCHEDULE SIGNIFICANT LOWERED ARIA-E RATES VERSUS ORIGINAL SCHEDULE

Source text: [ID:]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI